drugset / Trial / NCT03703856
Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease
NaSingle-groupOpen-labelTreatment
Summary
The effects of the medication, memantine, on brain functions and the symptoms of Alzheimer's Disease will be tested
Timeline
- Start
- 2019-01-31
- Primary completion
- 2025-01-08
- Completion
- 2025-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Memantine | Unknown | 10 mg | Oral |
| Subject | Memantine | Unknown | 20 mg | Oral |